Trials / Completed
CompletedNCT05602064
Effectiveness of Pre-emptive Analgesics on Post-Operative Pain After Stainless Steel Crown Placement On Primary Molars
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- Alexandria University · Academic / Other
- Sex
- All
- Age
- 5 Years – 8 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to evaluate the effectiveness of pre-emptive analgesia using ibuprofen and paracetamol on reducing post-operative pain following the placement of stainless steel crowns on primary molars compared to placebo
Detailed description
The study will be a parallel, placebo-controlled, triple-blinded, randomized clinical trial. A total of 66 healthy children aged 5-8 years requiring the placement of a stainless steel crown will be selected from Pediatric Dentistry and Dental Public Health Department, Faculty of Dentistry, Alexandria University, Egypt. The children will be randomly allocated into three groups according to the type of pre-emptive solution used. Group I will receive ibuprofen, group II will receive paracetamol, while group III (control) will receive a placebo solution. Children will self-report their level of pain using a Visual analogue scale (VAS) and/or a Facial pain scale (FPS) after local anesthesia administration, immediately after the cementation of the stainless steel crown, and 2, 6 and 24 hours post-operatively. Children's baseline anxiety and parental anxiety will also be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ibuprofen | Ibuprofen is a non-steroidal anti-inflammatory drug which acts by reducing the production of cyclo-oxygenases (COX-1 and COX-2)- derived prostanoids in the blood |
| DRUG | Paracetamol | Paracetamol is an analgesic that acts peripherally; although its primary site of action is still debatable, it is thought to inhibit prostaglandins in the hypothalamus |
| OTHER | Placebo | A placebo solution will be freshly prepared by an assistant in a manner to match the color and odor of the analgesics |
Timeline
- Start date
- 2022-11-01
- Primary completion
- 2023-02-01
- Completion
- 2023-02-20
- First posted
- 2022-11-01
- Last updated
- 2023-02-23
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05602064. Inclusion in this directory is not an endorsement.